SCHEMBL8288792

SCHEMBL8288792

O=C(NO)c1ccc(-c2cccc(CNCCN3CCCCC3)c2)o1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.47
DPP7 Q9UHL4 2/20 0.47
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
MAP4K4 O95819 1/20 0.43
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GAA P10253 1/20 0.43
MMP13 P45452 4/20 0.43
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 3/20 0.41
TSHR P16473 2/20 0.41
MEN1 O00255 1/20 0.41
PRKD3 O94806 1/20 0.41
PRKD1 Q15139 1/20 0.41
PRKD2 Q9BZL6 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8288789 0.99 DPP7 (0.48) ATRDPP7HSP90AA1HSP90AB1MAP4K4
SCHEMBL5446779 0.88 DPP7 (0.49) DPP7HPGDSMN1; SMN2KMT2AALDH1A1
SCHEMBL5453726 0.87 DPP7 (0.50) DPP7HPGDSMN1; SMN2KMT2AALDH1A1
SCHEMBL14449047 0.81 MMP13 (0.49) MMP13NPC1RAB9A
SCHEMBL5453734 0.81 ALDH1A1 (0.53) DPP7HPGDSMN1; SMN2KMT2AALDH1A1
SCHEMBL4420246 0.80 HDAC1 (0.54) HPGDKMT2AALDH1A1MEN1NPC1
SCHEMBL4424883 0.80 HDAC8 (0.55) HPGDSMN1; SMN2GAAALDH1A1L3MBTL1
SCHEMBL8288785 0.79 HDAC1 (0.50) ATRDPP7HSP90AA1HSP90AB1MAP4K4
SCHEMBL4422119 0.78 HDAC1 (0.49) HPGDALDH1A1L3MBTL1NPC1
SCHEMBL5444760 0.78 ALDH1A1 (0.59) HSP90AA1HPGDSMN1; SMN2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
WO-2005040161-A1 BIARYL LINKED HYDROXAMATES: PREPARATION AND PHARMACEUTICAL APPLICATIONS S*BIO PTE LTD (SG) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications HDAC1, HDAC11, HDAC2 ATR 2987/4885DPP7 1463/4885HSP90AA1 1172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.